Shionogi has agreed to acquire Sciele Pharma for US$1.4 B in another instance of a Japanese pharmaceutical company taking over a US company. The changes in the local industry within Japan have fuelled this trend, though it is now increasingly likely that Japanese pharmaceuticals are simply trying to keep up with their competitors’ global strategies.